Ypsomed Holding AG (SWX:YPSN)

Market Cap	4.64B
Revenue (ttm)	748.87M
Net Income (ttm)	87.50M
Shares Out	13.65M
EPS (ttm)	6.41
PE Ratio	53.04
Forward PE	24.66
Dividend	2.20 (0.65%)
Ex-Dividend Date	Jul 4, 2025

Volume	17,445
Average Volume	19,846
Open	342.50
Previous Close	340.00
Day's Range	333.50 - 348.50
52-Week Range	261.00 - 441.50
Beta	1.00
RSI	62.87
Earnings Date	Nov 12, 2025

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insu...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1984
• Employees: 2,644
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: YPSN

Financial Performance

In 2024, Ypsomed Holding AG's revenue was 748.87 million, an increase of 36.54% compared to the previous year's 548.46 million. Earnings were 87.50 million, an increase of 11.66%.